Iron Deficiency Workup
Diagnose iron deficiency using a ferritin cutoff of <45 ng/mL in patients with anemia, then proceed with systematic evaluation based on patient demographics and risk factors. 1
Initial Diagnostic Testing
Laboratory confirmation requires:
Serum ferritin <45 ng/mL (strong recommendation, high-quality evidence) 2, 1
- This threshold provides 85% sensitivity and 92% specificity for iron deficiency
- The traditional cutoff of <15 ng/mL misses too many cases (only 59% sensitivity)
Additional tests in special populations:
- Patients with chronic inflammation or chronic kidney disease may have falsely elevated ferritin
- Consider supplementary testing: serum iron, transferrin saturation, soluble transferrin receptor, or C-reactive protein 2
Risk Stratification and Evaluation Pathway
Postmenopausal Women and Men (All Ages)
Perform bidirectional endoscopy (EGD + colonoscopy) at the same session (strong recommendation, moderate-quality evidence) 2, 1
This aggressive approach is justified because:
- Recurrent blood loss accounts for 94% of cases in this population 3
- Risk of GI malignancy necessitates thorough evaluation
- Must rule out other unequivocal explanations first (frequent blood donation, vegan/vegetarian diet, non-GI blood loss, malabsorption)
Premenopausal Women
Consider bidirectional endoscopy over iron replacement alone (conditional recommendation, moderate-quality evidence) 1
Key decision points:
- If patient is <40 years with clear menstrual blood loss etiology: may defer endoscopy initially 4
- If heavy menstrual bleeding is documented: treat gynecologic cause + provide iron supplementation 3
- Patients who highly value avoiding endoscopy risk and have plausible alternative explanations may reasonably choose initial iron therapy 1
Additional Testing for All Patients
Celiac Disease Screening
Perform serologic testing first; only proceed to small bowel biopsy if positive (conditional recommendation, very low-quality evidence) 1
- Celiac disease causes IDA even in asymptomatic patients
- Cost-effective stepwise approach
Helicobacter pylori Testing
Use non-invasive testing; treat if positive (conditional recommendation, low-quality evidence) 1
- Common reversible cause of iron malabsorption
- Should be performed in conjunction with endoscopy when indicated
Atrophic Gastritis
Do NOT perform routine gastric biopsies (conditional recommendation, very low-quality evidence) 1
- Low yield unless specific clinical suspicion
After Negative Bidirectional Endoscopy
Initiate trial of iron supplementation over routine video capsule endoscopy (conditional recommendation, very low-quality evidence) 1
Exception - Proceed directly to capsule endoscopy if:
- Patient on anticoagulation/antiplatelet therapy where identifying small bowel pathology changes management
- Red flags present: involuntary weight loss, abdominal pain, elevated CRP 4
- Persistent anemia despite adequate iron repletion
Common Pitfalls to Avoid
Using ferritin <15 ng/mL threshold: Misses 41% of iron deficiency cases 2
Overreliance on hemoglobin alone: Iron deficiency can exist without anemia, particularly in menstruating women with flawed sex-specific reference ranges 5
Incomplete pre-referral workup: Studies show 78% of patients referred for small bowel evaluation had inadequate prior investigation 6
- Must complete quality colonoscopy (recent, total, adequate preparation)
- Must investigate H. pylori during EGD
- Must screen for celiac disease
Skipping endoscopy in young patients with "obvious" causes: Even patients with documented menstrual bleeding may harbor concurrent GI pathology—nearly 20% have additional upper or lower GI tract findings 6
Inadequate follow-up: Only 15% of patients receive appropriate hemoglobin follow-up testing 7
- Reassess in 2-4 weeks after initiating oral iron 3
- If no response, consider IV iron or further investigation
Quality Standards for Endoscopy
When bidirectional endoscopy is performed:
- Colonoscopy must be: recent, complete to cecum, with adequate bowel preparation 6
- EGD must include: H. pylori investigation 6
- Both procedures should occur in the same session for efficiency 2
The evidence strongly supports this systematic, risk-stratified approach to maximize detection of serious pathology (including malignancy) while balancing procedural risks and costs. The 2020 AGA guidelines provide the most comprehensive, evidence-based framework for this evaluation 2, 1.